Targeting KRAS: from metabolic regulation to cancer treatment
Peking University · Peking University Third Hospital
Abstract
The Kirsten rat sarcoma viral oncogene homolog (KRAS) protein plays a key pathogenic role in oncogenesis, cancer progression, and metastasis. Numerous studies have explored the role of metabolic alterations in KRAS-driven cancers, providing a scientific rationale for targeting metabolism in cancer treatment. The development of KRAS-specific inhibitors has also garnered considerable attention, partly due to the challenge of acquired treatment resistance. Here, we review the metabolic reprogramming of glucose, glutamine, and lipids regulated by oncogenic KRAS, with an emphasis on recent insights into the relationship between changes in metabolic mechanisms driven by KRAS mutant and related advances in targeted…
Citation impact
- FWCI
- 34.40
- Percentile
- 100%
- References
- 223
Authors
7- YSYanyan Shi
Peking University, Peking University Third Hospital
- HZHuiling Zheng
Peking University, Peking University Third Hospital
- TWTianzhen Wang
Peking University, Peking University Third Hospital
- SZShengpu Zhou
Peking University, Peking University Third Hospital
- SZShiqing Zhao
Peking University, Peking University Third Hospital
Topics & keywords
- KRAS
- Biology
- Colorectal cancer
- Cancer
- Cancer research
- Carcinogenesis
- Metabolic adaptation
- Pancreatic cancer
- Good health and well-being